Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,008 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
Saito D, Maeshima Y, Nasu T, Yamasaki H, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Saito D, et al. Among authors: tanabe k. Am J Physiol Renal Physiol. 2011 Apr;300(4):F873-86. doi: 10.1152/ajprenal.00503.2010. Epub 2011 Jan 12. Am J Physiol Renal Physiol. 2011. PMID: 21228103 Free article.
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy model (Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Diabete …
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy …
Renal distribution of Vasohibin-1 in patients with chronic kidney disease.
Hinamoto N, Maeshima Y, Saito D, Yamasaki H, Tanabe K, Nasu T, Watatani H, Ujike H, Kinomura M, Sugiyama H, Sonoda H, Kanomata N, Sato Y, Makino H. Hinamoto N, et al. Among authors: tanabe k. Acta Med Okayama. 2014;68(4):219-33. doi: 10.18926/AMO/52788. Acta Med Okayama. 2014. PMID: 25145408 Free article.
Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.
Hinamoto N, Maeshima Y, Yamasaki H, Nasu T, Saito D, Watatani H, Ujike H, Tanabe K, Masuda K, Arata Y, Sugiyama H, Sato Y, Makino H. Hinamoto N, et al. Among authors: tanabe k. PLoS One. 2014 Sep 25;9(9):e107934. doi: 10.1371/journal.pone.0107934. eCollection 2014. PLoS One. 2014. PMID: 25255225 Free PMC article.
The Efficacy of Rituximab in High-risk Renal Transplant Recipients.
Araki M, Wada K, Mitsui Y, Kubota R, Yoshioka T, Ariyoshi Y, Kobayashi Y, Kitagawa M, Tanabe K, Sugiyama H, Wada J, Watanabe M, Watanabe T, Hotta K, Nasu Y. Araki M, et al. Among authors: tanabe k. Acta Med Okayama. 2016 Aug;70(4):295-7. doi: 10.18926/AMO/54507. Acta Med Okayama. 2016. PMID: 27549676 Free article.
An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
Kobayashi R, Wakui H, Azushima K, Uneda K, Haku S, Ohki K, Haruhara K, Kinguchi S, Matsuda M, Ohsawa M, Toya Y, Nishiyama A, Yamashita A, Tanabe K, Maeshima Y, Umemura S, Tamura K. Kobayashi R, et al. Among authors: tanabe k. Kidney Int. 2017 May;91(5):1115-1125. doi: 10.1016/j.kint.2016.10.035. Epub 2017 Jan 10. Kidney Int. 2017. PMID: 28081856 Free article.
3,008 results